DE3675115D1 - Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star. - Google Patents

Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.

Info

Publication number
DE3675115D1
DE3675115D1 DE8686830226T DE3675115T DE3675115D1 DE 3675115 D1 DE3675115 D1 DE 3675115D1 DE 8686830226 T DE8686830226 T DE 8686830226T DE 3675115 T DE3675115 T DE 3675115T DE 3675115 D1 DE3675115 D1 DE 3675115D1
Authority
DE
Germany
Prior art keywords
medicine
compounds
producing
treating gray
gray star
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686830226T
Other languages
English (en)
Inventor
Michele Testa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT48447/85A external-priority patent/IT1200104B/it
Priority claimed from IT22596/85A external-priority patent/IT1201483B/it
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3675115D1 publication Critical patent/DE3675115D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8686830226T 1985-08-05 1986-07-31 Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star. Expired - Lifetime DE3675115D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48447/85A IT1200104B (it) 1985-08-05 1985-08-05 Prodotto farmaceutico ad attivita' anti-cataratta e procedimento per la sua produzione
IT22596/85A IT1201483B (it) 1985-10-23 1985-10-23 Prodotti farmaceutici ad attivita' anti-cataratta e composizioni che li contengono

Publications (1)

Publication Number Publication Date
DE3675115D1 true DE3675115D1 (de) 1990-11-29

Family

ID=26328230

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686830226T Expired - Lifetime DE3675115D1 (de) 1985-08-05 1986-07-31 Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.

Country Status (5)

Country Link
US (1) US4797422A (de)
EP (1) EP0213091B1 (de)
DE (1) DE3675115D1 (de)
DK (1) DK335086A (de)
FR (1) FR2585571A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871350A (en) * 1986-11-04 1989-10-03 Baylor College Of Medicine Methods and compositions for preventing secondary cataracts
US4966577A (en) * 1988-03-16 1990-10-30 Allergan, Inc. Prevention of lens-related tissue growth in the eye
US5271939A (en) * 1988-10-03 1993-12-21 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5627162A (en) * 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
US5459133A (en) * 1992-06-05 1995-10-17 Telor Ophthalmic Pharmaceuticals, Inc. Methods and products for treating presbyopia
AU4653993A (en) * 1992-07-02 1994-01-31 Telor Ophthalmic Pharmaceuticals, Inc. Methods and products for treating presbyopia
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US10507245B2 (en) 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2222976A (en) * 1937-11-15 1940-11-26 Sharp & Dohme Inc Nasal drops
US2631169A (en) * 1950-09-12 1953-03-10 Gen Aniline & Film Corp Method for preparing substituted hydroxy benzyl alcohol
US3037057A (en) * 1959-01-23 1962-05-29 Union Carbide Corp Production of aromatic aminoalcohols
CH506480A (de) * 1969-02-20 1971-04-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen, substituierten o-Anilino-phenäthylalkoholen
US3679804A (en) * 1969-05-01 1972-07-25 Geigy Chem Corp Method for treating glaucoma with alkyl gallates
DE2441621A1 (de) * 1974-08-30 1976-03-11 Robugen Gmbh Arzneimittel zur behandlung von augenerkrankungen
JPS51125035A (en) * 1974-10-09 1976-11-01 Shionogi & Co Ltd New process for preparing 0-hydroxybenzylalcohols
US4087538A (en) * 1976-09-09 1978-05-02 Merck & Co., Inc. Ophthalmic suspensions
US4136178A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
DE2729075A1 (de) * 1977-06-28 1979-01-18 Haarmann & Reimer Gmbh Verfahren zur herstellung von reinem 2-hydroxybenzylalkohol, reinem 4-hydroxybenzylalkohol oder einem gemisch beider hydroxybenzylalkohole
US4198522A (en) * 1977-09-27 1980-04-15 American Cyanamid Company 4-(Monoalkylamino)phenyl carbinols and ester derivatives
FR2413348A1 (fr) * 1977-12-31 1979-07-27 Dynamit Nobel Ag Procede pour l'obtention d'alcools benzyliques
FR2430928A1 (fr) * 1978-07-11 1980-02-08 Rhone Poulenc Ind Procede de preparation des alcools orthohydroxybenzyliques
US4351826A (en) * 1980-02-29 1982-09-28 Massachusetts Institute Of Technology Process for preventing or reversing cataract formation using acrylamides
FR2508440B1 (fr) * 1981-06-25 1985-11-08 Saint Gobain Isover Procede de preparation d'alcools orthohydroxybenzyliques
DE3332507A1 (de) * 1983-09-09 1985-03-28 Henkel Kgaa Sebosuppressive kosmetische mittel enthaltend benzylalkohol-derivate
US4615877A (en) * 1984-02-27 1986-10-07 Savapa S.R.L. Method of determining the oxidizing activity of a biological liquid, and a corresponding reagent
JPS6261941A (ja) * 1985-09-11 1987-03-18 Mitsui Toatsu Chem Inc m−ヒドロキシベンズアルデヒドの製造方法
JPH114509A (ja) * 1997-06-12 1999-01-06 Hitachi Ltd 配電用変電所

Also Published As

Publication number Publication date
EP0213091B1 (de) 1990-10-24
DK335086D0 (da) 1986-07-15
EP0213091A1 (de) 1987-03-04
FR2585571A1 (fr) 1987-02-06
US4797422A (en) 1989-01-10
DK335086A (da) 1987-02-06

Similar Documents

Publication Publication Date Title
DE3888177D1 (de) Schnellauflösbare arzneimitteldosierungseinheit sowie verfahren zur herstellung.
DE68924831D1 (de) Verfahren zur Herstellung von Poly-n-Butylenen mittels Organo-Aluminium-Halogenidkatalysatoren.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
DE3484055D1 (de) Verwendung von ubidecarenon zur herstellung eines medikaments zur behandlung von durch radiotherapie hervorgerufenen geschwueren.
DE3585607D1 (de) Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet.
DE3785740D1 (de) Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE68924714T2 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE3675115D1 (de) Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
DE58908451D1 (de) Verfahren zur Herstellung von Organochlorsilanen.
DE3785530D1 (de) Verfahren zur herstellung von l-arginin.
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE58906613D1 (de) Verfahren zur Herstellung von orthodontischen Teilen.
ATA232687A (de) Zahnpflegemittel, sowie verfahren zur herstellung des zahnpflegemittels
DE3681033D1 (de) Katalytisches verfahren zur herstellung von fluoraomatischen verbindungen mittels n-sek-alkylpyridiniumsalze.
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
ATE135220T1 (de) Verwendung von 1-alpha,24(r)-dihydroxy-22(e)- dehydrovitamin-d3 zur herstellung eines arzneimittels zur behandlung der osteoporose
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3853968D1 (de) Verfahren zur Herstellung von Vitronectin.
DE68920087D1 (de) Verfahren zur Herstellung von Neuraminidase.
DE3686097D1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE3873210D1 (de) Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
DE69012279D1 (de) Verfahren zur Herstellung ungesättigter Verbindungen.
DE69300037T2 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69620786T2 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee